| Structure | Chemical Name | CAS | MF |
|
1-(1-phenyl-1H-tetrazol-5-yl)methanamine(SALTDATA: HCl)
|
165736-06-1
|
C8H9N5
|
|
1-(2,4-Dimethyl-1,3-thiazol-5-yl)methanamine
|
165736-07-2
|
C6H10N2S
|
|
Imidazo[1,2-a]pyridin-2-yl-methylamine dihydrochloride
|
165736-20-9
|
C8H9N3
|
|
(5-Bromobenzo[b]furan-2-yl)methylamine
|
165736-51-6
|
C9H8BrNO
|
|
2-Buten-1-amine,3-(2-methyl-6-benzothiazolyl)-(9CI)
|
165736-98-1
|
C12H14N2S
|
|
2-Benzofuranmethanamine, 7-amino-
|
165737-01-9
|
C9H10N2O
|
|
(5-Bromobenzo[b]thiophen-2-yl)methanamine
|
165737-02-0
|
C9H8BrNS
|
|
3-Benzofuranmethanamine, 2-methyl-
|
165737-04-2
|
C10H11NO
|
|
2-Benzofuranmethanamine, 4-amino-
|
165737-05-3
|
C9H10N2O
|
|
2-Benzofuranmethanamine, 6-amino-
|
165737-06-4
|
C9H10N2O
|
|
2-Benzofuranmethanamine, 5-methyl-
|
165737-47-3
|
C10H11NO
|
|
2-Benzofuranmethanamine, 7-methyl-
|
165737-48-4
|
C10H11NO
|
|
Loratadine N-Oxide
|
165739-62-8
|
C22H23ClN2O3
|
|
3-Methoxy desloratadine
|
165739-63-9
|
C20H21ClN2O
|
|
Loratadine 2-Chloro IMpurity
|
165739-64-0
|
C22H22Cl2N2O2
|
|
8-Chloro-3-methoxy-5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-β]pyridin-11- one
|
165739-70-8
|
C15H12ClNO2
|
|
8-Chloro-3-methoxy-11-(1-methyl-4-piperidinyl)-6,11-dihydro-5H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ol
|
165739-71-9
|
C21H25ClN2O2
|
|
3-Methoxy-N-methyldesloratadine
|
165739-72-0
|
C21H23ClN2O
|
|
3-Methoxy Loratadine
|
165739-73-1
|
C23H25ClN2O3
|
|
4-chloro-loratadine
|
165739-83-3
|
C22H22Cl2N2O2
|
|
Desloratadine N-Carboxylic Acid Methyl Ester
|
165740-03-4
|
C21H21ClN2O2
|
|
N-Methyl-3,4-dimethylbenzylamine
|
165741-71-9
|
C10H15N
|
|
1H-Pyrazole-3-carboxylicacid,1,5-diethyl-(9CI)
|
165743-59-9
|
C8H12N2O2
|
|
Ethanone, 1-(1,5-diethyl-1H-pyrazol-3-yl)- (9CI)
|
165743-61-3
|
C9H14N2O
|
|
Ethanone, 1-(1-ethyl-5-methyl-1H-pyrazol-3-yl)- (9CI)
|
165743-69-1
|
C8H12N2O
|
|
Ethanone, 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-3-yl]- (9CI)
|
165743-84-0
|
C8H12N2O2
|
|
1H-Pyrazole-3-carboxylicacid,5-ethyl-1-methyl-,ethylester(9CI)
|
165744-14-9
|
C9H14N2O2
|
|
5-Ethyl-1-methyl-1H-pyrazole-3-carboxylic acid
|
165744-15-0
|
C7H10N2O2
|
|
Ethanone, 1-(5-ethyl-1-methyl-1H-pyrazol-3-yl)- (9CI)
|
165744-17-2
|
C8H12N2O
|
|
GERMALL PLUS
|
165745-27-7
|
C16H26IN5O9
|
|
PESTAHIVIN
|
165754-55-2
|
C53H84N8O9
|
|
Linezolid
|
165800-03-3
|
C16H20FN3O4
|
|
eperezolid
|
165800-04-4
|
C18H23FN4O5
|
|
orbofiban acetate
|
165800-05-5
|
C17H23N5O4.C2H4O2
|
|
Zoledronic acid hydrate
|
165800-06-6
|
C5H10N2O7P2.H2O
|
|
Zoledronate disodium tetrahydrate
|
165800-07-7
|
C5H13N2NaO8P2
|
|
Acetylated hydrogenated cottonseed glyceride
|
165800-53-3
|
|
|
m-Butoxybromobenzene
|
165800-57-7
|
C10H13BrO
|
|
3-Iodo-4-methylbenzyl alcohol 97
|
165803-89-4
|
C8H9IO
|
|
Methyl 2-fluoro-5-formylbenzoate
|
165803-94-1
|
C9H7FO3
|
|
n-Propyl 3-mercaptopropionate
|
165804-07-9
|
C6H12O2S
|
|
1-Propanone, 2-amino-1-(5-amino-1H-imidazol-4-yl)-
|
165804-14-8
|
C6H10N4O
|
|
SB 220025
|
165806-53-1
|
C18H19FN6
|
|
N-[(4-Fluorophenyl)((4-methylphenyl)sulfonyl)methyl]formamide
|
165806-94-0
|
C15H14FNO3S
|
|
α-(p-Toluenesulfonyl)-4-fluorobenzylisonitrile
|
165806-95-1
|
C15H12FNO2S
|
|
Cyclopropanamine, N-(4-pyridinylmethylene)- (9CI)
|
165806-97-3
|
C9H10N2
|
|
2-Propanamine,N-(4-pyridinylmethylene)-(9CI)
|
165806-98-4
|
C9H12N2
|
|
4-Dimethoxymethylpyrimidin-2-ylamine
|
165807-05-6
|
C7H11N3O2
|
|
2-Aminopyrimidine-4-carbaldehyde
|
165807-06-7
|
C5H5N3O
|
|
Ethyl 2-amino-5-(4-methoxy-phenyl)-4-methyl-thiophene-3-carboxylate
|
165809-38-1
|
C15H17NO3S
|
|
3-Cyclohexen-1-one, 5-(hydroxymethyl)-3-methoxy-, (R)- (9CI)
|
165812-20-4
|
C8H12O3
|
|
6-Acethyoxy-8-methyl-8-azabicyclo(3.2.1)octan-3-one
|
165813-66-1
|
C10H15NO3
|
|
4H-Cyclopenta[b]thiophene-3-carbonitrile,5,6-dihydro-2-(1H-pyrrol-1-yl)-(9CI)
|
165820-24-6
|
C12H10N2S
|
|
1-Piperazinecarboxaldehyde, 3,5-dioxo- (9CI)
|
165824-59-9
|
C5H6N2O3
|
|
3-Amino-2-cyano-N-phenyl-3-(4-phenylpiperazino)-2-propenethioamide
|
165824-75-9
|
C20H21N5S
|
|
4-Amino-2-anilino-5-benzoyl-3-thiophenecarbonitrile
|
165824-82-8
|
C18H13N3OS
|
|
Acetoxy-TMS-ethynylbenzen
|
165825-13-8
|
C13H16O2Si
|
|
.beta.-D-Glucopyranoside, 2-propenyl 2-(acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-, 3-methanesulfonate
|
165874-19-1
|
C19H25NO8S
|
|
.beta.-D-Glucopyranoside, 2-propenyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-4,6-O-(phenylmethylene)-, 3-(trifluoromethanesulfonate)
|
165874-20-4
|
C25H22F3NO9S
|
|
.beta.-D-Allopyranoside, 2-propenyl 2-(acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-
|
165874-21-5
|
C18H23NO6
|
|
.beta.-D-Allopyranoside, 2-propenyl 2-(acetylamino)-2-deoxy-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-
|
165874-22-6
|
C25H29NO6
|
|
.beta.-D-Allopyranose, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-
|
165874-23-7
|
C28H25NO7
|
|
.beta.-D-Allopyranose, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-, 1-(2,2,2-trichloroethanimidate)
|
165874-24-8
|
C30H25Cl3N2O7
|
|
.beta.-D-Allopyranoside, 2-propenyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-
|
165874-25-9
|
C31H29NO7
|
|
.beta.-D-Allopyranoside, 2-propenyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-4,6-O-(phenylmethylene)-
|
165874-26-0
|
C24H23NO7
|
|
.alpha.-D-Allopyranoside, 2-propenyl 2-deoxy-4-O-2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-.beta.-D-allopyranosyl-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,6-bis-O-(phenylmethyl)-
|
165874-27-1
|
C59H54N2O13
|
|
.beta.-D-Allopyranose, 2-deoxy-4-O-2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-.beta.-D-allopyranosyl-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,6-bis-O-(phenylmethyl)-
|
165874-28-2
|
C56H50N2O13
|
|
.beta.-D-Allopyranose, 2-deoxy-4-O-2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-(phenylmethylene)-.beta.-D-allopyranosyl-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,6-bis-O-(phenylmethyl)-, 1-(2,2,2-trichloroethanimidate)
|
165874-29-3
|
C58H50Cl3N3O13
|
|
1H-2,5-Methanocyclopenta[c]pyrrol-4-amine,hexahydro-,
|
165874-34-0
|
C8H14N2
|
|
Cyclohexanone, 5-methyl-2-(1-methylethyl)-, oxime, (2R,5S)- (9CI)
|
165874-36-2
|
C10H19NO
|
|
3,3-Dimethyl-1-nitrobut-1-ene
|
165881-29-8
|
C6H11NO2
|
|
(1S,2S,3R,5S)-(+)-2,3-Pinanediol 4-bromobutylboronate ester
|
165881-36-7
|
C14H24BBrO2
|
|
phorboxazole A
|
165883-76-1
|
C53H71BrN2O13
|
|
R-Viniferin
|
165883-77-2
|
C56H42O12
|
|
D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3,4-bis(dihydrogen phosphate)
|
165883-85-2
|
C41H81O19P3
|
|
Siloxanes and silicons, di-Me, 3-(ethylamino)-2-methylpropyl group terminated
|
165883-95-4
|
|
|
1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, 11-chloro-2,3,3a,12b-tetrahydro-2-Methyl-, (3aR,12bS)-rel-
|
165890-26-6
|
C17H14ClNO2
|
|
H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH
|
165893-48-1
|
C42H86N28O8
|
|
2,5-Dibenzyltetrahydropyrrolo[3,4-c]pyrrole-1,3-dione
|
165893-99-2
|
C20H20N2O2
|
|
Pyrrolo[3,4-c]pyrrole, octahydro-2,5-bis(phenylMethyl)-
|
165894-00-8
|
C20H24N2
|
|
3,7-Diazabicyclo[3.3.0]Octane dihydrochloride
|
165894-01-9
|
C6H14Cl2N2
|
|
tert-butyl 6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate
|
165894-06-4
|
C11H17N3O2
|
|
4,5,6,7-Tetrahydro-pyrazolo[1,5-a]pyrazine, dihydrochloride
|
165894-07-5
|
C6H9N3.2ClH
|
|
7-Benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
|
165894-09-7
|
C13H15N3
|
|
5,6,7,8-Tetrahydroimidazo[1,5-a]pyrazine dihydrochloride
|
165894-10-0
|
C6H11Cl2N3
|
|
1,4-Dinitro-2,3-piperazinedione
|
165896-98-0
|
C4H4N4O6
|
|
Di-n-heptyldiethyltin
|
165900-80-1
|
C18H40Sn
|
|
6-aminopyridine-3-carboxylic acid
|
165901-22-4
|
C12H10N2O2S
|
|
1H-IMidazole, 2-(4-fluorophenyl)-4,5-dihydro-
|
165901-26-8
|
C9H9FN2
|
|
2-Trimethylsilyl-1-ethylboronic acid pinacol ester
|
165904-20-1
|
C11H25BO2Si
|
|
2-Phenylethyl-1-boronic acid pinacol ester
|
165904-22-3
|
C14H21BO2
|
|
3,3-Diethoxy-1-propylboronic acid pinacol ester
|
165904-27-8
|
C13H27BO4
|
|
3-Trimethylsilyl-1-propylboronic acid pinacol ester
|
165904-32-5
|
C12H27BO2Si
|
|
Calystegine A5
|
165905-26-0
|
C7H13NO3
|
|
Merpentan
|
165942-79-0
|
|
|
Eph ligand family 2 protein, mammalian
|
165945-35-7
|
|
|
YL-1 protein
|
165945-72-2
|
|
|
4-Pyrimidinamine, 5-bromo-6-methyl-2-(methylthio)-
|
165946-79-2
|
C6H8BrN3S
|
|
Boc-N-methyl-tranexamic acid
|
165947-29-5
|
C14H25NO4
|
|
5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid
|
165947-48-8
|
C13H17NO4S
|